FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer

BACKGROUND: Chemotherapy is one of the primary treatments for ovarian cancer patients. Autophagy has been linked to chemotherapy resistance in tumor cells. Recent studies have suggested that fibroblast growth factor 19 (FGF19) may be involved in the onset and progression of malignancies. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wei, Huang, Meiyuan, Thakur, Abhimanyu, Yan, Yuanliang, Wu, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Biochemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899438/
https://www.ncbi.nlm.nih.gov/pubmed/36751636
http://dx.doi.org/10.7717/peerj.14827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899438/
https://www.ncbi.nlm.nih.gov/pubmed/36751636
http://dx.doi.org/10.7717/peerj.14827

Ejemplares similares